Novo Nordisk has struggled to meet the demand ... The company sold its pen needles and blood glucose monitoring systems (BGM) business to Medical Technology and Devices (MTD) for an undisclosed ...

(Bloomberg) -- Novo Nordisk A/S is following in rival ... Novo’s direct-to-consumer medicine will come in a pen device with a hidden needle. However, as Novo will only provide Wegovy to patients ...

It has been estimated that 90% of medical device waste consists of single-use products or components, so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living ...

Novo Nordisk has decided that it wants its own triple agonist, and is willing to hand over $200 million upfront to United Laboratories’ subsidiary United Biotechnology. In return for the global ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.